Webinar on INKmune, a Natural Killer Therapy for a Phase I/II Trial in Metastatic Prostate Cancer

Webinar to discuss INKmune™ in a phase I/II clinical trial for the treatment of men with mCRPC and provide details of the clinical trial design. RJ. Tesi, MD, will moderate a discussion between Prof. Matt Rettig, MD and Prof. Mark Lowdell, PhD.
#cancer #prostatecancer #INKmune #biotechnology #biology